Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Semaphorin 3A ELISA Kit (AC2811)
Cat.#: ASET-1400
Specifications
Description Mouse Semaphorin 3A ELISA Kit allows for the in vitro quantitative determination of mouse Semaphorin 3A concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2058 Mouse C Peptide ELISA Kit (AC3469) Quantitative inquiry ASET-1264 Rat TSH beta ELISA Kit (AC2675) Quantitative inquiry ASET-2027 Human Prion Protein PrP ELISA Kit (AC3438) Quantitative inquiry ASET-2492 Rat ERK1 + ERK2 ELISA Kit (AC3903) Quantitative inquiry ASET-1773 Mouse APPBP2 ELISA Kit (AC3184) Quantitative inquiry ASET-1690 Human Aspartate beta Hydroxylase ELISA Kit (AC3101) Quantitative inquiry ASET-2463 Human Syntenin ELISA Kit (AC3874) Quantitative inquiry ASET-2135 Human SNAP23 ELISA Kit (AC3546) Quantitative inquiry ASET-1368 Human NSMase2 ELISA Kit (AC2779) Quantitative inquiry ASET-1091 Human IRS1 ELISA Kit (AC2502) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket